monoclonal antibody drug pathway panitumumab drug pathway 2015-12-17T09:45:33Z PW:0002374 The pharmacokinetics and pharmacodynamics pathway of panitumumab, a human monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. pathway vpetri